Talaris Therapeutics Inc.
13F holders, Q3 2024 (September 30)1holders
$25.71avg. 13F price*
At the end of Q3 2024, 1 institutions reported holding Talaris Therapeutics Inc. in their 13F filings. The largest holder was Lindbrook Capital, LLC ($1K).
- Company
- Talaris Therapeutics Inc.
- Filed as
- TOURMALINE BIO INC COM (Q3 2024)
- CUSIP
- 87410C104
- Latest filing quarter
- Q3 2024
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $1K |
| Exits | 0 | $0 |
Ownership 1 holders
| Lindbrook Capital, LLC | 0.00% | New | 56 | $1K |
"% of holder's portfolio" is TALARIS THERAPEUTICS INC's weight in each manager's 13F, not the share of Talaris Therapeutics Inc. the manager owns.